《外圍股市》美股期貨好淡爭持 道指期貨跑贏續升29點
美國經濟數據表現參差,亞太區股市個別發展。港股扭三連升,今天在友邦(01299.HK)、安踏(02020.HK)、銀娛(00027.HK)、九倉置業(01997.HK)、阿里健康(00241.HK)、蒙牛(02319.HK)、創科(00669.HK)及藥明生物(02269.HK)跌逾1%-3%拖累,由逾兩個月高位曾吐逾200點,低見29,251,現造29,274,回吐193點或近0.7%;滬深股市也吐近0.8%-1.2%;印度及新加坡股市吐0.9%及0.7%。相反,菲股反彈3.2%,大馬、澳洲及假後重開印尼股市升近0.8%-1.2%;日經反覆回升不足0.5%。
美股繼昨天先升後回後,期貨好淡爭持,道指期貨報34,579,續升29點;昨天輕微倒跌標普五百期貨報4,199,微升1點;昨天倒跌納指一百期貨現造13,647,續吐1點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.